Invitation to Bid - Povidone Iodine lotion 5 percent bott of 100 ml,Titotropium Bromide Inhaler 9 mcg,MDI Levosalbutamo in DARJEELING, WEST BENGAL

The eligibility requirements specify that bidders must be a registered entity capable of delivering pharmaceutical products as per the tender's terms. Bidders should demonstrate compliance with necessary quality standards and hold applicable certifications.

Bidders must provide various certificates including a valid manufacturing license, quality assurance certificates, and any specific documentation that validates compliance with the regulations set by pharmaceutical authorities.

The registration process typically involves creating an account on the official tender platform, providing requisite details about your organization, and completing any KYC documentation as specified by the issuing authority.

The tender explicitly requires bidders to submit documents in specified formats, which can include PDF and Word formats. The details regarding accepted formats are outlined in the tender documents.

All products must comply with national and international quality standards, verifying their safety and efficacy. Bidders should demonstrate adherence to the stipulated quality benchmarks in their submissions.

Bidders must ensure their products comply with all relevant local and international regulations pertaining to pharmaceutical manufacturing and distribution. This includes certifications and adherence to safety protocols.

Yes, submitted products will undergo rigorous testing criteria as defined by the relevant health authorities to ensure they meet the safety and quality specifications required.

The Earnest Money Deposit (EMD) is outlined in the tender documentation. It acts as a financial guarantee to ensure that the bid is serious and compliant with the proposed terms.

The performance security requirements necessitate a guarantee from the bidder to fulfill the contract obligations, ensuring that products are delivered on time and in the specified quality.

Payment terms will be determined as part of the contractual arrangement and may include milestone-based payments upon successful delivery and acceptance of goods.

The price evaluation will consider the overall competitiveness and compliance of the proposal with the tender specifications. Cost-effectiveness while meeting quality standards will be prioritized.

Bidders are required to electronically submit all tender documents via the official tender submission portal. Physical submissions are generally not accepted unless specifically stated.

Specific key timelines and deadlines for bid submissions, evaluations, and notifications of results are delineated within the tender documentation, and bidders should strictly adhere to these schedules.

The evaluation and selection process involves a thorough assessment of submitted bids based on compliance, quality, pricing, and capacity to meet delivery requirements.

Notification of results will generally be communicated to bidders post-evaluation, as described in the tender documents, assuring transparency throughout the selection process.

Benefits for MSEs participating in this tender include opportunities for reduced qualification criteria and potential price preferences to encourage fair bidding alongside larger enterprises.

Yes, the tender encourages participation from startups through relaxed criteria and provisions that enhance their ability to compete effectively within the pharmaceutical sector.

Bidders must provide necessary documentation that outlines adherence to 'Make in India' policies and demonstrate the sourcing of materials and products from within India where applicable.

Local content procurement rules encourage bidders to utilize local resources in manufacturing and sourcing, fostering indigenous production while ensuring compliance with the tender’s quality requirements.